News
Important Only
Schimek: New strategic investors supporting Bolttech’s bid to close trillion-dollar protection gap
By Chris MunroJune 6 - (The Insurer) - Bolttech’s new strategic investors Iberis Capital and Sumitomo Corporation offer far more than just funding as they also provide meaningful support to the insurtech’s bid to close the trillion-dollar protection gap, founder and CEO Rob Schimek has told The Insu...Reuters
Tue, Jun 10
Bausch And Lomb Announces Launch Of Senior Secured Notes Offering, Refinancing Of Credit Agreement
June 10 (Reuters) - Bausch + Lomb Corp BLCO.TO:BAUSCH + LOMB ANNOUNCES LAUNCH OF SENIOR SECURED NOTES OFFERING AND REFINANCING OF CREDIT AGREEMENTBAUSCH + LOMB CORP - LAUNCHES €600 MILLION SENIOR SECURED NOTES OFFERINGBAUSCH + LOMB CORP - LAUNCHES $2.2 BILLION NEW TERM B LOAN FACILITYBAUSCH + LOMB C...Reuters
Tue, Jun 10
US issues sanctions against charities supporting Hamas, PFLP, Treasury website shows
WASHINGTON, June 10 (Reuters) - The United States imposed sanctions on Tuesday targeting individuals and sham charities that it said were prominent financial supporters of the Palestinian groups Hamas and the Popular Front for the Liberation of Palestine, the Treasury Department website showed.Reuters
Tue, Jun 10
CORRECTED-USAID cuts threaten 'God's food,' made in Georgia for children in need
MANA Nutrition, other aid groups face funding cuts from USAID under Trump administrationMANA seeks new funding partners to continue fight against child malnutritionPhilanthropist Chris Hohn has donated over $250 million to MANA By Rich McKayFITZGERALD, Georgia, June 9 (Reuters) - Reaching into one o...Reuters
Tue, Jun 10
Aspire Biopharma CEO Kraig Higginson Steps Down - SEC Filing
June 10 (Reuters) - Aspire Biopharma Holdings Inc ASBP.O:ASPIRE BIOPHARMA HOLDINGS INC - KRAIG HIGGINSON STEPS DOWN AS CEO OF ASPIRE BIOPHARMA - SEC FILINGASPIRE BIOPHARMA HOLDINGS INC - HIGGINSON TO REMAIN AS CHAIRMAN OF ASPIRE BIOPHARMA - SEC FILINGASPIRE BIOPHARMA HOLDINGS INC - MICHAEL HOWE APPO...Reuters
Tue, Jun 10
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program
June 10 (Reuters) - Neuronetics Inc STIM.O:NEURONETICS ANNOUNCES CLINICAL PRESENCE AT THE 2025 CLINICAL TMS SOCIETY ANNUAL MEETING AND PROGRESS IN GREENBROOK’S PERSONALIZED CARE TRIAL PROGRAMReuters
Tue, Jun 10
